Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.
Identifieur interne : 000334 ( Pmc/Curation ); précédent : 000333; suivant : 000335Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.
Auteurs : T. Cherian ; L. Bobo ; M C Steinhoff ; R A Karron ; R H YolkenSource :
- Journal of Clinical Microbiology [ 0095-1137 ] ; 1994.
Abstract
Influenza A virus infections are a major cause of morbidity and mortality worldwide. Standard diagnostic methods either are not efficient in identifying infected individuals in a timely manner or lack sensitivity. We developed a PCR-enzyme immunoassay (PCR-EIA) for the detection of influenza A virus RNA in respiratory secretions. A reverse transcription PCR was performed with oligonucleotide primers directed at a highly conserved area of the influenza A matrix gene. Amplified DNA was identified by hybridization in solution to a nested biotinylated RNA probe and quantitated in an EIA. PCR-EIA detected small quantities of RNA from the three prevalent subtypes of human influenza A virus. Influenza B and C, parainfluenza, measles, mumps, and respiratory syncytial viruses tested negative. The potential efficiency of PCR-EIA for use in clinical diagnosis was determined by testing 90 nasal wash specimens obtained daily over a 10-day period from nine human volunteers infected with influenza A virus. Thirty-seven of the postinfection samples had detectable influenza A virus RNA by PCR-EIA, whereas only 26 postinfection samples were positive by culture. PCR-EIA was particularly efficient for the identification of influenza A virus in samples obtained more than 4 days after infection. Seventeen of 45 such samples were positive, whereas virus was cultivated from 4 samples (P < 0.00005). All preinfection samples from volunteers subsequently infected with influenza A virus were negative by PCR-EIA, as were samples from a volunteer infected with parainfluenza virus type 3. Nucleic acid amplification techniques represent important tools for the timely and sensitive diagnosis of influenza A virus infections and, therefore, their management and control.
Url:
PubMed: 8195369
PubMed Central: 263097
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000334
Links to Exploration step
PMC:263097Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.</title>
<author><name sortKey="Cherian, T" sort="Cherian, T" uniqKey="Cherian T" first="T" last="Cherian">T. Cherian</name>
</author>
<author><name sortKey="Bobo, L" sort="Bobo, L" uniqKey="Bobo L" first="L" last="Bobo">L. Bobo</name>
</author>
<author><name sortKey="Steinhoff, M C" sort="Steinhoff, M C" uniqKey="Steinhoff M" first="M C" last="Steinhoff">M C Steinhoff</name>
</author>
<author><name sortKey="Karron, R A" sort="Karron, R A" uniqKey="Karron R" first="R A" last="Karron">R A Karron</name>
</author>
<author><name sortKey="Yolken, R H" sort="Yolken, R H" uniqKey="Yolken R" first="R H" last="Yolken">R H Yolken</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">8195369</idno>
<idno type="pmc">263097</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC263097</idno>
<idno type="RBID">PMC:263097</idno>
<date when="1994">1994</date>
<idno type="wicri:Area/Pmc/Corpus">000334</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000334</idno>
<idno type="wicri:Area/Pmc/Curation">000334</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000334</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.</title>
<author><name sortKey="Cherian, T" sort="Cherian, T" uniqKey="Cherian T" first="T" last="Cherian">T. Cherian</name>
</author>
<author><name sortKey="Bobo, L" sort="Bobo, L" uniqKey="Bobo L" first="L" last="Bobo">L. Bobo</name>
</author>
<author><name sortKey="Steinhoff, M C" sort="Steinhoff, M C" uniqKey="Steinhoff M" first="M C" last="Steinhoff">M C Steinhoff</name>
</author>
<author><name sortKey="Karron, R A" sort="Karron, R A" uniqKey="Karron R" first="R A" last="Karron">R A Karron</name>
</author>
<author><name sortKey="Yolken, R H" sort="Yolken, R H" uniqKey="Yolken R" first="R H" last="Yolken">R H Yolken</name>
</author>
</analytic>
<series><title level="j">Journal of Clinical Microbiology</title>
<idno type="ISSN">0095-1137</idno>
<idno type="eISSN">1098-660X</idno>
<imprint><date when="1994">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Influenza A virus infections are a major cause of morbidity and mortality worldwide. Standard diagnostic methods either are not efficient in identifying infected individuals in a timely manner or lack sensitivity. We developed a PCR-enzyme immunoassay (PCR-EIA) for the detection of influenza A virus RNA in respiratory secretions. A reverse transcription PCR was performed with oligonucleotide primers directed at a highly conserved area of the influenza A matrix gene. Amplified DNA was identified by hybridization in solution to a nested biotinylated RNA probe and quantitated in an EIA. PCR-EIA detected small quantities of RNA from the three prevalent subtypes of human influenza A virus. Influenza B and C, parainfluenza, measles, mumps, and respiratory syncytial viruses tested negative. The potential efficiency of PCR-EIA for use in clinical diagnosis was determined by testing 90 nasal wash specimens obtained daily over a 10-day period from nine human volunteers infected with influenza A virus. Thirty-seven of the postinfection samples had detectable influenza A virus RNA by PCR-EIA, whereas only 26 postinfection samples were positive by culture. PCR-EIA was particularly efficient for the identification of influenza A virus in samples obtained more than 4 days after infection. Seventeen of 45 such samples were positive, whereas virus was cultivated from 4 samples (P < 0.00005). All preinfection samples from volunteers subsequently infected with influenza A virus were negative by PCR-EIA, as were samples from a volunteer infected with parainfluenza virus type 3. Nucleic acid amplification techniques represent important tools for the timely and sensitive diagnosis of influenza A virus infections and, therefore, their management and control.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><graphic xlink:href="jcm00003-0056-a" xlink:role="626"></graphic>
</fig>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Microbiol</journal-id>
<journal-title>Journal of Clinical Microbiology</journal-title>
<issn pub-type="ppub">0095-1137</issn>
<issn pub-type="epub">1098-660X</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">8195369</article-id>
<article-id pub-id-type="pmc">263097</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Cherian</surname>
<given-names>T</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Bobo</surname>
<given-names>L</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Steinhoff</surname>
<given-names>M C</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Karron</surname>
<given-names>R A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Yolken</surname>
<given-names>R H</given-names>
</name>
</contrib>
</contrib-group>
<aff>Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.</aff>
<pub-date pub-type="ppub"><month>3</month>
<year>1994</year>
</pub-date>
<volume>32</volume>
<issue>3</issue>
<fpage>623</fpage>
<lpage>628</lpage>
<abstract><p>Influenza A virus infections are a major cause of morbidity and mortality worldwide. Standard diagnostic methods either are not efficient in identifying infected individuals in a timely manner or lack sensitivity. We developed a PCR-enzyme immunoassay (PCR-EIA) for the detection of influenza A virus RNA in respiratory secretions. A reverse transcription PCR was performed with oligonucleotide primers directed at a highly conserved area of the influenza A matrix gene. Amplified DNA was identified by hybridization in solution to a nested biotinylated RNA probe and quantitated in an EIA. PCR-EIA detected small quantities of RNA from the three prevalent subtypes of human influenza A virus. Influenza B and C, parainfluenza, measles, mumps, and respiratory syncytial viruses tested negative. The potential efficiency of PCR-EIA for use in clinical diagnosis was determined by testing 90 nasal wash specimens obtained daily over a 10-day period from nine human volunteers infected with influenza A virus. Thirty-seven of the postinfection samples had detectable influenza A virus RNA by PCR-EIA, whereas only 26 postinfection samples were positive by culture. PCR-EIA was particularly efficient for the identification of influenza A virus in samples obtained more than 4 days after infection. Seventeen of 45 such samples were positive, whereas virus was cultivated from 4 samples (P < 0.00005). All preinfection samples from volunteers subsequently infected with influenza A virus were negative by PCR-EIA, as were samples from a volunteer infected with parainfluenza virus type 3. Nucleic acid amplification techniques represent important tools for the timely and sensitive diagnosis of influenza A virus infections and, therefore, their management and control.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><graphic xlink:href="jcm00003-0056-a" xlink:role="626"></graphic>
</fig>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000334 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000334 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:263097 |texte= Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:8195369" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a H2N2V1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |